Avantax Advisory Services Inc. Acquires Shares of 10,000 ASP Isotopes Inc. (NASDAQ:ASPI)

Avantax Advisory Services Inc. bought a new position in ASP Isotopes Inc. (NASDAQ:ASPI) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,000 shares of the company’s stock, valued at approximately $45,000.

A number of other institutional investors have also recently modified their holdings of the stock. Philadelphia Financial Management of San Francisco LLC raised its holdings in ASP Isotopes by 158.3% in the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after acquiring an additional 607,893 shares during the last quarter. Geode Capital Management LLC boosted its stake in ASP Isotopes by 42.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after purchasing an additional 334,836 shares during the last quarter. Walleye Capital LLC bought a new stake in shares of ASP Isotopes in the 3rd quarter worth $536,000. State Street Corp increased its holdings in shares of ASP Isotopes by 12.8% in the 3rd quarter. State Street Corp now owns 853,695 shares of the company’s stock worth $2,373,000 after purchasing an additional 96,604 shares in the last quarter. Finally, Barclays PLC lifted its holdings in shares of ASP Isotopes by 438.5% during the third quarter. Barclays PLC now owns 72,330 shares of the company’s stock valued at $201,000 after purchasing an additional 58,897 shares in the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI opened at $4.73 on Friday. The company has a market cap of $337.67 million, a PE ratio of -7.75 and a beta of 3.66. The firm’s 50-day moving average price is $5.04 and its 200-day moving average price is $4.89. ASP Isotopes Inc. has a 52-week low of $1.86 and a 52-week high of $9.33. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.